Presley Gerber’s death at a California rehab facility raises critical concerns about ibogaine treatment and the risks of allowing patients to direct their own addiction care.
The recent death of Presley Gerber, the 27-year-old son of supermodel Cindy Crawford, has ignited urgent discussions surrounding addiction treatment, particularly the use of ibogaine and the implications of patient-directed care. Gerber passed away on Sunday at a rehabilitation facility in California, prompting questions about how someone with access to extensive treatment resources could succumb to addiction.
Dr. Drew Pinsky, a well-known addiction specialist, has weighed in on the matter, emphasizing the progressive and often fatal nature of substance use disorders. He expressed concern over a troubling trend in modern addiction treatment: allowing patients to dictate their own care. “When I listened to [Gerber’s] video, what struck me and concerned me was that the patient seemed to be determining some of the care,” Pinsky stated during an episode of his podcast, “Ask Dr. Drew.” “That’s never good.”
Pinsky highlighted Gerber’s self-reported trip to Mexico for an “ibogaine flood,” a high-dose treatment involving ibogaine, a psychoactive compound derived from an African shrub. While ibogaine has been studied as a potential treatment for substance use disorders, it remains unapproved by the FDA. Pinsky cautioned that he has seen numerous patients attempt to use ibogaine or similar alternative therapies, but most eventually relapse on opioids, often experiencing significant personality changes in the process.
Ibogaine is classified as a Schedule I substance in the United States due to documented risks, including potentially fatal heart arrhythmias, according to federal health agencies. Pinsky argued that Gerber’s situation underscores how individuals grappling with severe substance use disorders are frequently allowed to bypass established medical protocols in favor of risky alternative therapies.
In light of the public shock surrounding Gerber’s death within a treatment center, Pinsky stressed that even high-end rehabilitation facilities cannot magically resolve severe opioid dependence. “Opioid addiction is progressive and it ends in death,” he warned. “Even with good treatment, it has a worse prognosis than most cancers. If they are not moving toward recovery, they are moving toward demise.”
While official toxicology results from the Los Angeles County Medical Examiner’s Office are still pending, emergency dispatch logs indicate that 911 was called to Gerber’s facility for a suspected overdose and cardiac arrest.
Dr. Nicholas Kardaris, an addiction expert and CEO of the New York Center for Living, echoed Pinsky’s concerns, noting that the period inside or immediately following rehabilitation is often the most perilous for patients. “People are in rehab because they’re struggling with addiction. It doesn’t mean they’re cured,” Kardaris explained. He pointed out that when patients relapse during treatment, their lowered tolerance can turn a typical dose into a potentially fatal one.
Medical professionals advocate that families seeking help for loved ones struggling with addiction should pursue evidence-based treatment from qualified providers. This includes the use of FDA-approved medications for opioid use disorders, such as buprenorphine, methadone, and naltrexone, when appropriate.
The tragic case of Presley Gerber serves as a stark reminder of the complexities of addiction treatment and the critical importance of adhering to established medical protocols. As discussions continue, experts stress the need for a balanced approach that prioritizes patient safety and evidence-based practices in the fight against substance use disorders.
According to Fox News, the ongoing conversation surrounding Gerber’s death highlights the urgent need for reform in addiction treatment practices.